20-HETE: Hypertension and Beyond.
作者信息
Roman Richard J, Fan Fan
机构信息
From the Department of Pharmacology, University of Mississippi Medical Center, Jackson.
出版信息
Hypertension. 2018 Jul;72(1):12-18. doi: 10.1161/HYPERTENSIONAHA.118.10269. Epub 2018 May 14.
Abstract
摘要
相似文献
1
20-HETE: Hypertension and Beyond.
Hypertension. 2018 Jul;72(1):12-18. doi: 10.1161/HYPERTENSIONAHA.118.10269. Epub 2018 May 14.
2
Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.
Hypertension. 2011 Apr;57(4):788-94. doi: 10.1161/HYPERTENSIONAHA.110.161570. Epub 2011 Feb 14.
3
20-HETE and Hypertension.
Hypertension. 2024 Oct;81(10):2012-2015. doi: 10.1161/HYPERTENSIONAHA.124.21718. Epub 2024 Aug 28.
4
Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.
Hypertension. 2007 Jul;50(1):123-9. doi: 10.1161/HYPERTENSIONAHA.107.089599. Epub 2007 Jun 4.
5
Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Am J Physiol Regul Integr Comp Physiol. 2015 Jul 1;309(1):R71-8. doi: 10.1152/ajpregu.00039.2015. Epub 2015 Apr 29.
6
Effect of 20-HETE inhibition on L-NAME-induced hypertension in rats.
Clin Exp Hypertens. 2018;40(3):292-302. doi: 10.1080/10641963.2017.1368540. Epub 2017 Oct 31.
7
Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
J Am Soc Nephrol. 2013 Jul;24(8):1288-96. doi: 10.1681/ASN.2012070714. Epub 2013 May 2.
8
Conflicting roles of 20-HETE in hypertension and renal end organ damage.
Eur J Pharmacol. 2018 Aug 15;833:190-200. doi: 10.1016/j.ejphar.2018.06.010. Epub 2018 Jun 7.
9
CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Hypertension. 2010 Nov;56(5):871-8. doi: 10.1161/HYPERTENSIONAHA.110.154559. Epub 2010 Sep 13.
10
Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans.
Circulation. 2004 Jul 27;110(4):438-43. doi: 10.1161/01.CIR.0000136808.72912.D9. Epub 2004 Jul 19.
引用本文的文献
1
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer.
FEBS Lett. 2025 Apr;599(7):927-951. doi: 10.1002/1873-3468.70013. Epub 2025 Feb 20.
2
20-HETE mediates Ang II-induced cardiac hypertrophy via ROS and Ca signaling in H9c2 cells.
Sci Rep. 2025 Jan 17;15(1):2342. doi: 10.1038/s41598-025-85992-2.
3
Oxylipins as therapeutic indicators of herbal medicines in cardiovascular diseases: a review.
Front Pharmacol. 2024 Dec 19;15:1454348. doi: 10.3389/fphar.2024.1454348. eCollection 2024.
4
Oxylipins Derived from PUFAs in Cardiometabolic Diseases: Mechanism of Actions and Possible Nutritional Interactions.
Nutrients. 2024 Nov 7;16(22):3812. doi: 10.3390/nu16223812.
5
20-HETE and Hypertension.
Hypertension. 2024 Oct;81(10):2012-2015. doi: 10.1161/HYPERTENSIONAHA.124.21718. Epub 2024 Aug 28.
6
Transcriptomic Analysis of Arachidonic Acid Pathway Genes Provides Mechanistic Insight into Multi-Organ Inflammatory and Vascular Diseases.
Genes (Basel). 2024 Jul 20;15(7):954. doi: 10.3390/genes15070954.
7
Eicosanoids and Oxylipin Signature in Hereditary Hemochromatosis Patients Are Similar to Dysmetabolic Iron Overload Syndrome Patients but Are Impacted by Dietary Iron Absorption.
Ann Nutr Metab. 2024;80(3):117-127. doi: 10.1159/000536657. Epub 2024 Feb 14.
8
The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells.
Eur J Drug Metab Pharmacokinet. 2023 Nov;48(6):709-722. doi: 10.1007/s13318-023-00857-1. Epub 2023 Oct 10.
9
Metabolic Responses of Normal Rat Kidneys to a High Salt Intake.
Function (Oxf). 2023 Jun 22;4(5):zqad031. doi: 10.1093/function/zqad031. eCollection 2023.
10
Genetic Variants of Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China.
Pharmgenomics Pers Med. 2023 Jun 15;16:599-607. doi: 10.2147/PGPM.S413632. eCollection 2023.
本文引用的文献
1
20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.
Nat Commun. 2018 Jan 12;9(1):177. doi: 10.1038/s41467-017-02539-4.
2
The Blood Pressure-Lowering Effect of 20-HETE Blockade in Mice Is Associated with Natriuresis.
J Pharmacol Exp Ther. 2017 Dec;363(3):412-418. doi: 10.1124/jpet.117.243618. Epub 2017 Sep 14.
3
Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.
J Am Soc Nephrol. 2017 Oct;28(10):2845-2855. doi: 10.1681/ASN.2017030252. Epub 2017 Jul 12.
4
GPR75 Identified as the First 20-HETE Receptor: A Chemokine Receptor Adopted by a New Family.
Circ Res. 2017 May 26;120(11):1696-1698. doi: 10.1161/CIRCRESAHA.117.311022.
5
20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G) to Affect Vascular Function and Trigger Hypertension.
Circ Res. 2017 May 26;120(11):1776-1788. doi: 10.1161/CIRCRESAHA.116.310525. Epub 2017 Mar 21.
6
Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid.
Curr Opin Nephrol Hypertens. 2017 Mar;26(2):74-82. doi: 10.1097/MNH.0000000000000302.
7
20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT/GSK-3β/Glut2 pathway.
Endocrine. 2016 Nov;54(2):371-382. doi: 10.1007/s12020-016-1031-5. Epub 2016 Aug 27.
8
20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.
J Biol Chem. 2016 Aug 5;291(32):16904-19. doi: 10.1074/jbc.M116.732297. Epub 2016 Jun 13.
9
Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.
Front Biosci (Landmark Ed). 2016 Jun 1;21(7):1427-63. doi: 10.2741/4465.
10
Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.
Adv Pharmacol. 2015;74:223-62. doi: 10.1016/bs.apha.2015.05.002. Epub 2015 Jun 27.
Zotero 插件